EuBiologics Co., Ltd. (KOSDAQ:206650)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,000
-250 (-1.89%)
Oct 10, 2025, 3:30 PM KST
-1.89%
Market Cap485.27B
Revenue (ttm)96.04B
Net Income (ttm)24.87B
Shares Out36.62M
EPS (ttm)n/a
PE Ratio19.52
Forward PE10.55
Dividendn/a
Ex-Dividend Daten/a
Volume167,306
Average Volume239,264
Open13,260
Previous Close13,250
Day's Range12,980 - 13,370
52-Week Range10,000 - 18,800
Beta0.46
RSI40.14
Earnings DateOct 28, 2025

About EuBiologics

EuBiologics Co., Ltd., a biopharmaceutical company, provides vaccines for pidemics in South Korea. It offers Euvichol, Euvichol Plus, and Euvichol-S, an oral cholera vaccine developed to prevent cholera; and EuCorVac-19, a subunit vaccine.The company also provides EcML, a vaccine for cell membrane, as well as offers COVID-19 diagnostic kits; and rCRM197, a diphtheria toxoid vaccine. In addition, it offers CMO services comprising of drug product production, cell bank production, drug product production, and drug substance production. Further, t... [Read more]

Sector Healthcare
Founded 2010
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 206650
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.